tirzepatide lab analysis on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide 45mg | GLP-1 Product

, , -- : - Very interesting paper just published in Cardiovascular Diabetology by Federica Marzano and colleagues

Analysis of EHR notes for on-treatment functional features showed reduced exercise tolerance was the strongest correlate of greater LBM loss, increasing by 7.2 and 11.1 percentage points in semaglutide- and tirzepatide-treated patients, respectively

Explore gastric sleeve vs gastric bypass

Fibroids (or leiomyoma or myomata) are the most common growth found in the womb

Understanding expiration timelines and proper storage helps you maintain consistent weight loss results and avoid complications from degraded medication

Metabolikus kutatsok vizsgljk hatst a lipidprofilra, vrnyomsra s energiamrlegre